Yuchun Lee - 12 Apr 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
12 Apr 2022
Net transactions value
-$810,900
Form type
4
Filing time
14 Apr 2022, 16:35:05 UTC
Previous filing
12 Apr 2022
Next filing
18 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $163,080 +2,000 +107% $81.54 3,875 12 Apr 2022 Direct
transaction VRTX Common Stock Sale $55,844 -200 -5.2% $279.22 3,675 12 Apr 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale $331,681 -1,182 -32% $280.61 2,493 12 Apr 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale $89,581 -318 -13% $281.70 2,175 12 Apr 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale $84,945 -300 -14% $283.15 1,875 12 Apr 2022 Direct F1, F2, F6
transaction VRTX Common Stock Options Exercise $163,080 +2,000 +107% $81.54 3,875 13 Apr 2022 Direct
transaction VRTX Common Stock Sale $5,067 -18 -0.46% $281.49 3,857 13 Apr 2022 Direct F1
transaction VRTX Common Stock Sale $85,119 -300 -7.8% $283.73 3,557 13 Apr 2022 Direct F1, F2, F7
transaction VRTX Common Stock Sale $64,957 -228 -6.4% $284.90 3,329 13 Apr 2022 Direct F1, F2, F8
transaction VRTX Common Stock Sale $85,872 -300 -9% $286.24 3,029 13 Apr 2022 Direct F1, F2, F9
transaction VRTX Common Stock Sale $57,484 -200 -6.6% $287.42 2,829 13 Apr 2022 Direct F1, F2, F10
transaction VRTX Common Stock Sale $115,420 -400 -14% $288.55 2,429 13 Apr 2022 Direct F1, F2, F11
transaction VRTX Common Stock Sale $58,034 -200 -8.2% $290.17 2,229 13 Apr 2022 Direct F1, F2, F12
transaction VRTX Common Stock Sale $103,056 -354 -16% $291.12 1,875 13 Apr 2022 Direct F1, F2, F13

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -2,000 -25% $0.000000 6,000 12 Apr 2022 Common Stock 2,000 $81.54 Direct F14
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -2,000 -33% $0.000000 4,000 13 Apr 2022 Common Stock 2,000 $81.54 Direct F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
F2 Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $279.22 (range $279.14 to $279.30).
F4 Open market sales reported on this line occurred at a weighted average price of $280.61 (range $280.24 to $281.19).
F5 Open market sales reported on this line occurred at a weighted average price of $281.70 (range $281.45 to $281.98).
F6 Open market sales reported on this line occurred at a weighted average price of $283.15 (range $282.73 to $283.57).
F7 Open market sales reported on this line occurred at a weighted average price of $283.73 (range $283.30 to $284.10).
F8 Open market sales reported on this line occurred at a weighted average price of $284.90 (range $284.66 to $284.95).
F9 Open market sales reported on this line occurred at a weighted average price of $286.24 (range $285.99 to $286.60).
F10 Open market sales reported on this line occurred at a weighted average price of $287.42 (range $287.02 to $287.83).
F11 Open market sales reported on this line occurred at a weighted average price of $288.55 (range $288.23 to $289.11).
F12 Open market sales reported on this line occurred at a weighted average price of $290.17 (range $289.72 to $290.62).
F13 Open market sales reported on this line occurred at a weighted average price of $291.12 (range $290.80 to $291.42).
F14 Fully vested.